The USFDA Chief supports Generics made in India
Indian drug companies have gotten an attempt within the arm with the US Food and Drug Administration (USFDA) chief beginning in support of generics manufactured in India and therefore the US to dispel fears over such medicines.
Generics account for 90% of the US drug market — up from 33% three decades ago. FDA Commissioner Scott Gottlieb’s statement boosted the S&P BSE Healthcare index, which gained 0.7% on Monday.
For Indian drug makers, whose major a part of business comes from the sale of generics within the US, Gottlieb’s statement has given a respite from the poor perception of generics as well as Indian-made drugs.
“Generic drugs are even as safe and effective as their branded drug counterparts… Generic medicines use equivalent active ingredients as brand-name medicines and work an equivalent way, in order that they have an equivalent risks and benefits,” Gottlieb wrote during a newsletter on February 22.